Creating Effective Models for Delivering Palliative Care in Advanced Liver Disease

Manisha Verma, Marie A Bakitas, Manisha Verma, Marie A Bakitas

Abstract

Purpose of review: The current healthcare system is not fully equipped to provide comprehensive support for patients with advanced liver disease (ALD) and their caregivers resulting in concomitant suffering and reduced quality of life (QoL). Integration of palliative care (PC) within routine care has demonstrated benefits in improving symptoms and QoL and reducing healthcare utilization for other serious illnesses but has been underutilized or delayed for ALD care. The purpose of this article is to outline the domains and benefits of PC and discuss the misconceptions and barriers for PC integration, and healthcare delivery models supporting PC integration within ALD care.

Recent findings: PC has eight key domains related to physical and mental health, goals for future care, and care of the caregivers. PC offers benefits to improve health outcomes and patient satisfaction and reduce healthcare utilization. To date there have been successful models of PC that are primarily hospital- or community-based; successful models have been PC specialist- or primary/generalist-led.

Summary: Concurrent PC within oncology has formed the basis for most evidence-based guidelines. PC integration within ALD care is still in its infancy. While amassing evidence in ALD, hepatology organizations can promote consensus-based integrated PC models that can guide research and practice efforts to increase supportive care for these patients in need and their family caregivers.

Keywords: Advanced liver disease; Models of palliative care.

Conflict of interest statement

Conflict of interestManisha Verma and Marie A. Bakitas declare that they have no conflict of interest.

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.

Figures

Fig. 1
Fig. 1
A proposed model of concurrent palliative care for ALD, including transplant evaluation

References

    1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. Bmj. 2018;362:k2817. doi: 10.1136/bmj.k2817.
    1. Centers for Disease Control. Health, United States 2017 with special feature on mortality. (accessed March 16, 2020)
    1. Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, Sherman RL, Wu M, Benard VB, Richardson LC, Jemal A, Cronin K, Kohler BA. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020;126:2225–2249. doi: 10.1002/cncr.32802.
    1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, etal Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi: 10.1002/ijc.31937.
    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee et al. Heart disease and stroke statistics—2019 update: a report from the American heart association. Circulation. 2019;139(10):e56–e528. doi: 10.1161/CIR.0000000000000659.
    1. Peng JK, Hepgul N, Higginson IJ. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med. 2019;33(1):24–36. doi: 10.1177/0269216318807051.
    1. Stepanova M, De Avila L, Afendy M, Younossi I, Pham H, Cable R, Younossi ZM. Direct and indirect economic burden of chronic liver disease in the United States. Clin Gastroenterol Hepatol. 2017;15(5):759–766. doi: 10.1016/j.cgh.2016.07.020.
    1. Xu F, Tong X, Leidner AJ. Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase. Health Aff. 2014;33(10):1728–1735. doi: 10.1377/hlthaff.2014.0096.
    1. Shrestha D, Rathi S, Grover S, Taneja S, Duseja A, Chawla YK, Dhiman RK. Factors affecting psychological burden on the informal caregiver of patients with cirrhosis: looking beyond the patient. J Clin Exp Hepatol. 2020;10(1):9–16. doi: 10.1016/j.jceh.2019.06.002.
    1. Hareendran A, Devadas K, Sreesh S, Tom Oommen T, Varghese J, Lubina S, Nahaz N, Krishna A, Mullali Mohamed Kunhi N. Quality of life, caregiver burden and mental health disorders in primary caregivers of patients with cirrhosis. Liver Int. 2020;40:2939–2949. doi: 10.1111/liv.14614.
    1. Nguyen DL, Chao D, Ma G, Morgan T. Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients. Ann Gastroenterol. 2015;28(1):124.
    1. Larson AM. Palliative care for patients with end-stage liver disease. Curr Gastroenterol Rep. 2015;17(5):440. doi: 10.1007/s11894-015-0440-6.
    1. Low JT, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, Stone P. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69(6):1260–1273. doi: 10.1016/j.jhep.2018.08.028.
    1. Woodrell CD, Hansen L, Schiano TD, Goldstein NE. Palliative care for people with hepatocellular carcinoma, and specific benefits for older adults. Clin Ther. 2018;40(4):512–525. doi: 10.1016/j.clinthera.2018.02.017.
    1. Ufere NN, O'Riordan DL, Bischoff KE, Marks AK, Eneanya N, Chung RT, et al. Outcomes of palliative care consultations for hospitalized patients with liver disease. J Pain Symptom Manag. 2019;58(5):766–773. doi: 10.1016/j.jpainsymman.2019.07.011.
    1. National Consensus Project . Clinical practice guidelines for quality palliative care. 4. Richmond: National consensus project for quality palliative care; 2018.
    1. Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ. Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35:96–112. doi: 10.1200/JCO.2016.70.1474.
    1. Braun LT, Grady KL, Kutner JS, Adler E, Berlinger N, Boss R, et al. Palliative care and cardiovascular disease and stroke: a policy statement from the American Heart Association/American Stroke Association. Circulation. 2016;134(11):e198–e225. doi: 10.1161/CIR.0000000000000438.
    1. Ahluwalia SC, Chen C, Raaen L, Motala A, Walling AM, Chamberlin M, O'Hanlon C, Larkin J, Lorenz K, Akinniranye O, Hempel S. A systematic review in support of the national consensus project clinical practice guidelines for quality palliative care. J Pain Symptom Manag. 2018;56(6):831–870. doi: 10.1016/j.jpainsymman.2018.09.008.
    1. Quinn KL, Shurrab M, Gitau K, Kavalieratos D, Isenberg SR, Stall NM, et al. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis. JAMA. 2020;324(14):1439–1450. doi: 10.1001/jama.2020.14205.
    1. Kamal AH, LeBlanc TW, Meier DE. Better palliative care for all: improving the lived experience with cancer. JAMA. 2016;31:2016.
    1. Scibetta C, Kerr K, Mcguire J, Rabow MW. The costs of waiting: implications of the timing of palliative care consultation among a cohort of decedents at a comprehensive cancer center. J Palliat Med. 2016;19(1):69–75. doi: 10.1089/jpm.2015.0119.
    1. Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: a systematic review. Jama. 2008;299(14):1698–1709. doi: 10.1001/jama.299.14.1698.
    1. Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, Hoydich ZP, Ikejiani DZ, Klein-Fedyshin M, Zimmermann C, Morton SC, Arnold RM, Heller L, Schenker Y. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316(20):2104–2114. doi: 10.1001/jama.2016.16840.
    1. Hoerger M, Greer JA, Jackson VA, Park ER, Pirl WF, El-Jawahri A, et al. Defining the elements of early palliative care that are associated with patient-reported outcomes and the delivery of end-of-life care. J Clin Oncol. 2018;36(11):1096–1102. doi: 10.1200/JCO.2017.75.6676.
    1. Esteban JPG, Rein L, Szabo A, et al. Attitudes of liver and palliative care clinicians toward specialist palliative care consultation for patients with end-stage liver disease. J Palliat Med. 2019;22:804–813. doi: 10.1089/jpm.2018.0553.
    1. Ufere NN, Donlan J, Waldman L, Dienstag JL, Friedman LS, Corey KE, et al. Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease. Clin Gastroenterol Hepatol. 2019;17:2592–2599. doi: 10.1016/j.cgh.2019.03.022.
    1. Quill TE, Abernethy AP. Generalist plus specialist palliative care — creating a more sustainable model. N Engl J Med. 2013;368(13):1173–1175. doi: 10.1056/NEJMp1215620.
    1. Lupu D, Force PMWT. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manag. 2010;40(6):899–911. doi: 10.1016/j.jpainsymman.2010.07.004.
    1. Quill TE, Abernethy AP. Generalist plus specialist palliative care—creating a more sustainable model. N Engl J Med. 2013;368(13):1173–1175. doi: 10.1056/NEJMp1215620.
    1. Verma, M, et al. (2020). Development, feasibility and acceptability of an online course to teach primary palliative care skills to hepatology providers. AASLD annual meeting. This abstract describes the key elements of a training program for hepatologists on primary palliative care skills.
    1. Firth AM, O’Brien SM, Guo P, Seymour J, Richardson H, Bridges C, et al. Establishing key criteria to define and compare models of specialist palliative care: a mixed-methods study using qualitative interviews and Delphi survey. Palliat Med. 2019;33(8):1114–1124. doi: 10.1177/0269216319858237.
    1. Harrison KL, Kotwal AA, Smith AK. Palliative care for patients with noncancer illnesses. JAMA. 2020;324(14):1404–1405. doi: 10.1001/jama.2020.15075.
    1. Brereton L, Clark J, Ingleton C, et al. What do we know about different models of providing palliative care? Findings from a systematic review of reviews. Palliat Med. 2017;31(9):781–797. doi: 10.1177/0269216317701890.
    1. Weissman DE, Meier DE. Operational features for hospital palliative care programs: consensus recommendations. J Palliat Med. 2008;11:1189–1194. doi: 10.1089/jpm.2008.0149.
    1. National Quality Forum . A national framework and preferred practices for palliative and hospice care quality: A Consensus Report. Washington, DC: National Quality Forum; 2006.
    1. Center to Advance Palliative Care. America’s care of serious illness: a state-by-state report card on access to palliative care in our nation’s hospitals. New York; 2019.
    1. Schoenherr LA, Bischoff KE, Marks AK, O’Riordan DL, Pantilat SZ. Trends in hospital-based specialty palliative care in the United States from 2013 to 2017. JAMA Netw Open. 2019;2(12):e1917043. doi: 10.1001/jamanetworkopen.2019.17043.
    1. El-Jawahri A, LeBlanc T, VanDusen H, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316:2094–2103. doi: 10.1001/jama.2016.16786.
    1. Courtright KR, Madden V, Gabler NB, Cooney E, Small DS, Troxel A, et al. Rationale and design of the randomized evaluation of default access to palliative services (REDAPS) trial. Ann Am Thoracic Soc. 2016;13(9):1629–1639. doi: 10.1513/AnnalsATS.201604-308OT.
    1. Bagcivan G, Bakitas M, Palmore J, Kvale E, Nichols AC, Howell SL, Dionne-Odom JN, Mancarella GA, Osisami O, Hicks J, Huang CHS, Tucker R. Looking back, moving forward: a retrospective review of care trends in an academic palliative and supportive care program from 2004 to 2016. J Palliat Med. 2019;22(8):970–976. doi: 10.1089/jpm.2018.0410.
    1. Smith TJ, Coyne P, Cassel B, Penberthy L, Hopson A, Hager MA. A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. J Palliat Med. 2003;6(5):699–705. doi: 10.1089/109662103322515202.
    1. Morrison R, Meier D, Carlson M. The healthcare imperative: lowering costs and improving outcomes. Washington DC: Institute of Medicine; 2011.
    1. Calton BA, Alvarez-Perez A, Portman DG, et al. The current state of palliative care for patients cared for at leading US cancer centers: The 2015 NCCN. Palliative Care Survey. J Natl Compr Cancer Netw. 2016;14:859–866. doi: 10.6004/jnccn.2016.0090.
    1. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383:1721–1730. doi: 10.1016/S0140-6736(13)62416-2.
    1. Haun MW, Estel S. Ru¨ cker G, et al: Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017;6:CD011129.
    1. Calton BA, Alvarez-Perez A, Portman DG, Ramchandran KJ, Sugalski J, Rabow MW. The current state of palliative care for patients cared for at leading US cancer centers: The 2015 NCCN Palliative Care Survey. J Natl Compr Cancer Netw. 2016;14:859–866. doi: 10.6004/jnccn.2016.0090.
    1. Dalal S, Bruera S, Hui D, Yennu S, Dev R, Williams J, Masoni C, Ihenacho I, Obasi E, Bruera E. Use of palliative care services in a tertiary cancer center. Oncologist. 2016;21:110–118. doi: 10.1634/theoncologist.2015-0234.
    1. Hui D, Mori M, Watanabe SM, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016;17:e552–e559. doi: 10.1016/S1470-2045(16)30577-0.
    1. Cohn J, Corrigan J, Lynn J, Meier D, Miller J, Shega J, Wang S. Community-based models of care delivery for people with serious illness. NAM Perspectives. Discussion Paper. Washington, DC: National Academy of Medicine; 2017.
    1. Bakitas M, Lyons K, Hegel M, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–749. doi: 10.1001/jama.2009.1198.
    1. Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438–1445. doi: 10.1200/JCO.2014.58.6362.
    1. Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, Li Z, Frost J, Dragnev KH, Akyar I, Hegel MT, Bakitas MA. Benefits of early versus delayed palliative Care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1446–1452. doi: 10.1200/JCO.2014.58.7824.
    1. Calton B, Abedini N, Fratkin M. Telemedicine in the time of coronavirus. J Pain Symptom Manag. 2020;60:e12–e14. doi: 10.1016/j.jpainsymman.2020.03.019.
    1. Humphreys J, Schoenherr L, Elia G, Saks NT, Brown C, Barbour S, Pantilat SZ. Rapid implementation of inpatient telepalliative medicine consultations during COVID-19 pandemic. J Pain Symptom Manag. 2020;60:e54–e59. doi: 10.1016/j.jpainsymman.2020.04.001.
    1. Jiang B, Bills M, Poon P. Integrated telehealth-assisted home-based specialist palliative care in rural Australia: a feasibility study. J Telemed Telecare. 2020:1357633X20966466.
    1. Kuntz JG, Kavalieratos D, Esper GJ, Ogbu N, Jr, Mitchell J, Ellis CM. Feasibility and acceptability of inpatient palliative care e-family meetings during COVID-19 pandemic. J Pain Symptom Manag. 2020;60:e28–e32. doi: 10.1016/j.jpainsymman.2020.06.001.
    1. Shepperd S, Gonçalves-Bradley DC, Straus SE, et al. Hospital at home: home-based end-of-life care. Cochrane Database Syst Rev. 2016;2:CD009231.
    1. Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev. 2013;6.
    1. Australian Government. Australian institute of health and welfare. Service provider organisation: level of palliative care service 2007. . (accessed nov 8, 2020).
    1. Murray SA, Mitchell S, Boyd K, Moine S. Palliative care: training the primary care workforce is more important than rebranding. Bmj. 2019;365:l4119. doi: 10.1136/bmj.l4119.
    1. (accessed Nov 6, 2020)
    1. Ferrell BR, Sun V, Hurria A, Cristea M, Raz DJ, Kim JY, Reckamp K, Williams AC, Borneman T, Uman G, Koczywas M. Interdisciplinary palliative care for patients with lung cancer. J Pain Symptom Manag. 2015;50(6):758–767. doi: 10.1016/j.jpainsymman.2015.07.005.
    1. Verma M, Kosinski AS, Volk ML, Taddei T, Ramchandran K, Bakitas M, et al. Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial. J Palliat Med. 2019;22(S1):34–43. doi: 10.1089/jpm.2019.0121.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する